Vivodyne raised $40 million from Khosla Ventures and others
Vivodyne, a Penn spinout that creates human tissue to replace animal testing in drug development, has raised $40 million in a second round of venture capital investment. The company headquartered in Philadelphia’s Curtis building in Center City aims to speed up drug discovery and development, while eliminating the financial risk involved in testing treatments in